In contrast to VEGF-C, VEGFR3 immunoreactivity in gastric tumours is restricted to endothelial cells of mucosal and submucosal vessels that are regarded primarily as lymphatic vessels but also to a very few small blood vessels. Here, FLT4 is linked to gastric neoplasm.